Catalyst Pharmaceuticals, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CPRX research report →
About the company
Catalyst Pharmaceuticals, Inc. , founded in 2002 and based in Coral Gables, Florida, operates as a commercial-stage biopharmaceutical enterprise. This company is dedicated to discovering, developing, and marketing therapeutic solutions for individuals in the United States who are afflicted with uncommon, severe, and long-term neuromuscular and neurological disorders.
- CEO
- Richard John Daly
- IPO
- 2006
- Employees
- 181
- HQ
- Coral Gables, FL, US
Price Chart
- Market Cap
- $3.85B
- P/E
- 17.47
- P/S
- 6.45
- P/B
- 3.80
- EV/EBITDA
- 9.25
- Div Yield
- 0.00%
- Gross Margin
- 82.32%
- Op Margin
- 44.83%
- Net Margin
- 37.08%
- ROE
- 23.65%
- ROIC
- 19.67%
- Revenue
- $588.99M · 19.78%
- Net Income
- $214.33M · 30.78%
- EPS
- $1.75 · 26.81%
- Op Income
- $257.78M
- FCF YoY
- -12.81%
- 52W High
- $32.56
- 52W Low
- $19.05
- 50D MA
- $30.72
- 200D MA
- $24.95
- Beta
- 0.74
- Avg Volume
- 2.35M
Get TickerSpark's AI analysis on CPRX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 3, 25 | Andrews William T. | other | 3,052 |
| Jun 3, 26 | Andrews William T. | other | 3,052 |
| Jun 3, 26 | Andrews William T. | other | 743 |
| Feb 17, 26 | Russo Gregg | other | 687 |
| Feb 17, 26 | Russo Gregg | other | 687 |
| Feb 17, 26 | Russo Gregg | other | 211 |
| Jan 5, 26 | Kalb Michael Wayne | other | 7,139 |
| Jan 5, 26 | Kalb Michael Wayne | other | 7,139 |
| Jan 5, 26 | Kalb Michael Wayne | other | 2,080 |
| Jan 5, 26 | Daly Richard J | other | 42,105 |
Our CPRX coverage
Recent articles, reports, and earnings notes.
No research on CPRX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CPRX report →Similar companies
Peers in the same neighborhood.